Wednesday, 31 March 2021

High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients With Obesity

High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients With Obesity admin Wed, 03/31/2021 - 15:32

source https://www.pharmatutor.org/pharma-news/2021/high-liver-fat-hepatic-steatosis-linked-to-increased-risk-of-hospitalization-in-covid-19-patients-with-obesity

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...